Synthesis and pharmacologic properties of s-triazolo-1,4-diazepine derivatives
Guryn, R.; Szadowska, A.; Kiełek, M.B.
Acta Poloniae Pharmaceutica 45(6): 512-516
1988
ISSN/ISBN: 0001-6837 PMID: 3254673 Document Number: 316043
Document emailed within 1 workday
Related Documents
Monti, E.; Fornara, C.; Brembilla, E.; Dall'Oglio, A. 1984: Pharmacologic properties of etizolam (6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo 3,4-c thieno 2,3-e 1,4 diazepine) Minerva Psichiatrica 25(4): 269-274Casadio, S.; Cousse, H.; Mouzin, G.; Stenger, A.; Charveron, M.; Vilain, P.; Lauressergues, H. 1978: New beta-phenethylamine derivatives: Synthesis and pharmacologic properties Bollettino Chimico Farmaceutico 117(2): 83-89
Misztal, S.; Wiertek, J.; Rogóz, Z. 1976: Synthesis and pharmacologic properties of pyridoyl derivatives of 3-methylaminoindole 2-methyltryptamine and isotryptamine Archivum Immunologiae et Therapiae Experimentalis 24(6): 851-862
Thiele, K.; Jahn, U.; Geissmann, F.; Zirngibl, L. 1984: New biologically active theophylline derivatives. Synthesis and pharmacologic properties of flufylline and fluprofylline Arzneimittel-Forschung 34(1): 1-4
Holla, B.S.; Shivananda, M.K.; Akberali, P.M.; Baliga, S.; Safeer, S. 1996: Studies on arylfuran derivatives-Part VI. Synthesis, characterization and antibacterial activities of some 6-(5-aryl-2-furyl)-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and 6-(5-nitro-2-furyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles Farmaco 51(12): 785-792
Liszkiewicz, H.; Nawrocka, W.P.; Sztuba, B.; Wietrzyk, J.; Jaroszewicz, J.; Nasulewicz, A.; Pełczyńska, M. 2011: Synthesis and antiproliferative activity in vitro of new pyrido[1,4-b]diazepine derivatives and imidazo[4,5-b]pyridine Acta Poloniae Pharmaceutica 68(3): 349-355
Mazzone, G.; Bonina, F.; Pignatello, R.; Panico, A.M.; Caruso, A.; Leone, M.G.; Amico-Roxas, M.; Blandino, G. 1989: Carboxymethyl- and carboxy-derivatives of 7H- and 5H-1,2,4-triazolo [3,4-b][1,3,4] thiadiazine: synthesis and biological evaluation Farmaco 44(10): 933-944
Ali, K.A.; Ragab, E.A.; Farghaly, T.A.; Abdalla, M.M. 2011: Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents Acta Poloniae Pharmaceutica 68(2): 237-247
Baraldi, P.G.; Cacciari, B.; Spalluto, G.; Pineda de las Infants, M.J.; Zocchi, C.; Ferrara, S.; Dionisotti, S.; FerraDDionisotti, S. 1996: 1,2,3-Triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: a new class of A2A adenosine receptor antagonists Farmaco 51(4): 297-300
Delgado, F.; Pastor, J.; García-Navío, J.L.; Vaquero, J.J.; Alvarez-Builla, J.; Sunkel, C.; de Casa-Juana, M.F.; Priego, J.G.; Santos, L.R.; Statkow, P.R.; Straumann, D. 1997: Nonpeptide angiotensin Ii receptor antagonists: synthesis and biological activity of 1H-imidazo and 1H-[1,2,3]-triazolo fused derivatives Farmaco 52(3): 147-155
Rinaldi, M.; Pecorari, P.; Costantino, L.; Provvisionato, A.; Malagoli, M.; Cermelli, C. 1992: Synthesis and biological activity of new heterocyclic structures: [1,3]thiazino[2,3-i]purine, thiazolo[3,2-c] [1,2,3]triazolo[4,5-e]pyrimidine and [1,2,3]triazolo [4', 5': 4,5] pyrimido[6,1-b][1,3]thiazine Farmaco 47(10): 1315-1322
Schulz, U.; Freitag, M.; Schmidt, K.; Witetschek, M.; Polzin, M.; Morgenstern, O. 2014: Synthesis and structure elucidation of 2,3,5,6,7,8-hexahydro-1 H-[1,2,4]triazolo[1,2-a]pyridazine-1-thione, 3,3-disubstituted and 2-substituted derivatives and evaluation of their inhibitory activity against inducible nitric oxide synthase Die Pharmazie 69(10): 731-744
Krepelka, J.; Kotva, R.; Vachek, J.; Holubek, J.; Mĕlka, M.; Maturová, E.; Grimová, J. 1986: Synthesis and pharmacologic activity of pyrimidine derivatives Ceskoslovenska Farmacie 35(10): 433-439
Cebo, B.; Krupińska, J.; Mazur, J. 1979: Pharmacologic properties of some derivatives of N-(2-carboxyphenyl)-4-phenoxyacetamide Archivum Immunologiae et Therapiae Experimentalis 27(3): 415-424
Wilimowski, M.; Kedzierska, L.; Barczyńska, J.; Prandota, J. 1970: Pharmacologic properties of derivatives of 3-phenyl-3-hydroxyglutaric acid Archivum Immunologiae et Therapiae Experimentalis 18(2): 270-279
Kleinrok, Z.; Kozicka, M.; Tobiasz-Otrebska, K.; Sermak, W. 1985: Pharmacologic properties of new 5-benzylidene derivatives of 3-m-nitrophenyl-2-thiohydantoin Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 40: 169-176
Stefancich, G.; Artico, M.; Corelli, F.; Silvestri, R.; de Feo, G.; Mazzanti, G.; Durando, L.; Palmery, M. 1985: New psychotropic agents. I. Synthesis and pharmacologic activity of derivatives of 5H-imidazo-[2,1-c][1,4]benzodiazepine Il Farmaco; Edizione Scientifica 40(6): 429-441
Sokolov, G.P.; Freĭmanis, I.F.; Turovskiĭ, I.V.; Myshliakova, N.V. 1995: Total synthesis and properties of prostaglandins. XXXVIII. Synthesis of 11-deoxyprostaglandin-E1 derivatives with amino acids and amines Bioorganicheskaia Khimiia 21(5): 386-390
Thunus, L.; Lapiere, C.L. 1975: Synthesis and pharmacologic properties of some hydroxyethylpiperazinylpyridines (substitutions at 2-3 and 3-4) Annales Pharmaceutiques Francaises 33(12): 663-669
Anzini, M.; Cappelli, A.; Vomero, S.; Botta, M.; Cagnotto, A. 1990: 5-HT and benzodiazepine receptor ligands. III. Synthesis and receptor affinities of 1,2,4-triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one derivatives Farmaco 45(11): 1169-1179